Squamous Cell Carcinoma of the Lung
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Lung.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery [Phase 3]
Phase 3 trial evaluating gefitinib after complete surgical removal of stage IB to IIIA non-small cell lung cancer; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE
Observational study evaluating erlotinib as second-line treatment in patients with squamous cell non-small cell lung cancer and wild-type EG…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Ponatinib for Squamous Cell Lung and Head and Neck Cancers [Phase 2, Phase 3]
Ponatinib was studied in Phase 2/Phase 3 trials for squamous cell carcinoma of the lung and head and neck squamous cell carcinoma. The studi…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy [Phase 3]
Phase III trial comparing afatinib versus erlotinib in squamous cell non-small cell lung cancer after platinum-based therapy; results comple…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration. [Phase 3]
A Phase III trial evaluating rh-endostatin (Endostar) given as a continuous IV infusion plus GP chemotherapy versus GP chemotherapy alone in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung [Phase 2]
This document reports the completion of a Phase 2 trial evaluating Nab-Paclitaxel in advanced squamous cell carcinoma of the lung.
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Dasatinib in Advanced Squamous Cell Lung Cancer [Phase 2]
Phase 2 trial of dasatinib in advanced squamous cell carcinoma of the lung was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer [Phase 2]
A Phase 2 clinical trial assessing nab-paclitaxel as second-line therapy for locally advanced or metastatic squamous cell carcinoma of the l…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology [Phase 3]
A Phase 3 trial evaluating carboplatin and paclitaxel with or without the IGF-1R inhibitor CP-751,871 in advanced non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma [Phase 3]
A Phase 3 clinical trial update investigating metronomic cyclophosphamide with standard chemotherapy for squamous cell carcinoma of the lung…
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer [Phase 3]
Pfizer-sponsored Phase 3 trial evaluating figitumumab (CP-751,871) with erlotinib in refractory lung cancer was terminated and results were …
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing surgery with and without chemotherapy in patients with Stage I non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2013-06-07Clinical Trial Update: Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung [Phase 2]
Phase II neoadjuvant trial comparing nab-paclitaxel/carboplatin with paclitaxel/carboplatin in stage IIb and IIIA squamous cell carcinoma of…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating the combination of chemotherapy, radiation therapy, and gefitinib in patients with Stage III non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours [Phase 2]
Phase 2 proof-of-concept trial evaluating AZD4547 in FGFR1/FGFR2-amplified tumors, including gastric cancer, esophageal cancer, breast cance…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating erlotinib with radiation therapy and chemotherapy for inoperable Stage III non-small cell lung cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer [Phase 2]
Pfizer-sponsored Phase 2 trial evaluating AG-013736 with cisplatin and gemcitabine in patients with squamous non-small cell lung cancer; the…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) [Phase 2]
Phase II trial comparing maintenance temozolomide versus observation in stable or responding stage III/IV Non-Small Cell Lung Cancer. The st…
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment [Phase 2]
Phase II trial evaluating the combination of docetaxel and oxaliplatin as second-line therapy in advanced non-small cell lung cancer, includ…
-
CLINICAL_TRIALS research · 2010-06-29Clinical Trial Update: The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy [NA]
A clinical trial update investigating MDCT-derived perfusion parameters in lung adenocarcinoma and lung squamous cell carcinoma during radia…
-
CLINICAL_TRIALS trial_result · 2010-04-06Clinical Trial Update: A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) [Phase 2]
Phase 2 study of bevacizumab plus carboplatin and paclitaxel in advanced, previously untreated squamous non-small cell lung cancer has compl…
-
CLINICAL_TRIALS research · 2010-02-24Clinical Trial Update: Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer [Phase 1]
Phase 1 safety and effectiveness study of autologous natural killer and natural killer T cell therapy for multiple cancers is currently susp…